Home
Leadership
Investors
Technology
Grants
Contact
Papers
News
Rome, Italy |
info@neomatrixbiotech.com
|
Home
Leadership
Investors
Technology
Grants
Contact
Papers
News
Our Technology
The process
Tumor Biopsies are taken from patient
RNA and DNA are sequenced by Next Generation Sequencing
Synthetic linear DNA is manufactured in a dedicated GMP facility
The entire process is predicted to be back to the patient in 6 weeks
Tumor Biopsies are taken from patient
RNA and DNA are sequenced by Next Generation Sequencing
Neoantigens are identified through a pipeline called NARciso
Codon optimized vaccine is synthesized in our Laboratories
Synthetic linear DNA is manufactured in a dedicated GMP facility
The entire process is predicted to be back to the patient in 6 weeks
The process
© 2023 NEOMATRIX SRL | P. IVA 15698291000 | ALL RIGHTS RESERVED